Clinical Trial Update: An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States

View source ↗

Summary

This clinical trial update reports on an observational study evaluating the use of regorafenib in patients with advanced gastrointestinal stromal tumor in the U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Advanced Gastrointestinal Stromal Tumor | Status: COMPLETED